CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


WJ-MSCsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug793 Covidfree@home Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells

The purpose of this study is to investigate the potential use of Wharton's Jelly Mesenchymal stem cells (WJ-MSCs) for treatment of patient diagnosed with Corona Virus SARS-CoV-2 infection, and showing symptoms of COVID-19.

NCT04313322 Use of Stem Cells for COVID-19 Treatment Biological: WJ-MSCs

Primary Outcomes

Description: Improvement of clinical symptoms including duration of fever, respiratory destress, pneumonia, cough, sneezing, diarrhea.

Measure: Clinical outcome

Time: 3 weeks

Description: Side effects measured by Chest Readiograph

Measure: CT Scan

Time: 3 weeks

Description: Results of Real-Time Polymerase Chain Reaction of Viral RNA, Turing negative

Measure: RT-PCR results

Time: 3 weeks

Secondary Outcomes

Description: Results of Real-Time Polymerase Chain Reaction of Viral RNA, Turing negative

Measure: RT-PCR results

Time: 8 weeks


No related HPO nodes (Using clinical trials)